| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |